Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,505
Total Claims
$896K
Drug Cost
272
Beneficiaries
$3,294
Cost/Patient
Risk Score Breakdown 17/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-94%
Opioid rate vs peers
0.1% vs 2.2% avg
+133%
Cost per patient vs peers
$3,294 vs $1,411 avg
Opioid Prescribing
0.1%
Opioid Rate
14
Opioid Claims
$98
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 0 claims · $0
Generic: 8,821 claims · $257K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 272 | $73K |
| Bictegrav/Emtricit/Tenofov Ala | 11 | $44K |
| Rifaximin | 26 | $39K |
| Dulaglutide | 53 | $30K |
| Raltegravir Potassium | 12 | $24K |
| Budesonide/Formoterol Fumarate | 57 | $24K |
| Sitagliptin Phosphate | 76 | $23K |
| Rivaroxaban | 53 | $14K |
| Fluticasone/Vilanterol | 33 | $14K |
| Fluticasone/Umeclidin/Vilanter | 28 | $14K |
| Tiotropium Bromide | 33 | $13K |
| Risperidone Microspheres | 11 | $13K |
| Divalproex Sodium | 158 | $13K |
| Brexpiprazole | 25 | $13K |
| Insulin Glargine,hum.Rec.Anlog | 40 | $13K |
Prescribing Profile
Patient Profile
76
Avg Age
58%
Female
2.88
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data